$BSX Boston Scientific Corp. Company Overview
Boston Scientific Corp. develops, manufactures and markets medical devices that are used in a broad range of interventional medical specialties. The company's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. It operates its business through four geographic reportable segments: United States; EMEA, consisting of Europe, the Middle East and Africa; Japan and Inter-Continental, consisting of Asia Pacific and the Americas operating segments. The reportable segments represent an aggregate of all operating divisions within each segment. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Natick, MA.
BSX Last Price: 11.67
Last Updated: November 28, 2013 7:51 PM EST
BSX Stock Message Board and Forum http://investorshangout.com/search?q=BSX&...mp;yt0=Go!
Boston Scientific Corp. BSX Officers and Executives
Name Age Officer Since Title
Mr. Peter Michael Nicholas 71 1979 Chairman
Mr. Michael F. Mahoney 48 2011 President, Chief Executive Officer & Director
Mr. Kenneth J. Pucel 46 1989 EVP-Global Operations, Quality & Technology
Mr. Jeffrey D. Capello 48 2008 Chief Financial Officer & Executive Vice President
Dr. Keith D. Dawkins 62 2008 Global Chief Medical Officer & Executive VP
Boston Scientific Corp.
One Boston Scientific Place
Natick, Massachusetts 01760-1537
Phone
1 5086508000
Industry
Medical Equipment
Sector
Health Care
Fiscal Year-end
12/2013
View SEC Filings Below
Revenue
$7.25B
Net Income
$-4.07B
Employees
24,000
Annual Report Below for BSX
Boston Scientific Corp. BSX Recent Headlines
MarketWatch News on BSX
Best Buy falls 11% on warning; Tesla fires in focus 4:25 p.m. Nov. 19, 2013 - Sue Chang
Boston Scientific up on device OK; Medtronic stumbles on earnings 11:09 a.m. Nov. 19, 2013 - Russ Britt
A red flag against following billionaires’ trades 10:09 a.m. Nov. 15, 2013 - The Trading Deck
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Apple gains on Icahn letter, Muddy Waters hits NQ 3:26 p.m. Oct. 24, 2013 - Sue Chang
Boston Scientific loss narrows; adjusts guidance 6:49 a.m. Oct. 24, 2013 - MarketWatch.com
Ford, Microsoft, Amazon are stocks to watch 4:00 a.m. Oct. 24, 2013 - Sue Chang
What IBM’s revenue miss really means 9:51 a.m. Oct. 17, 2013 - Mark Hulbert
Bullish technicals vie with debt-ceiling deadline 11:38 a.m. Oct. 15, 2013 - Michael Ashbaugh
Bullish technicals vie with debt-ceiling deadline 11:22 a.m. Oct. 15, 2013 - Michael Ashbaugh
Device firms, Regeneron see gains while general markets fear shutdown 12:36 p.m. Sept. 30, 2013 - Russ Britt
One possible reason why device tax passed in the first place — soaring margins 1:32 p.m. Sept. 26, 2013 - Russ Britt
Investors don't see hope for repeal of Obamacare medical-device tax 10:36 a.m. Sept. 26, 2013 - Russ Britt
Dow industrials reclaim the 50-day average 10:55 a.m. Sept. 12, 2013 - Michael Ashbaugh
Groupon climbs to 14-month high close on upgrade 3:28 p.m. Sept. 5, 2013 - Sue Chang
Tuesday’s movers: Facebook takes a breather 3:41 p.m. Aug. 27, 2013 - Sue Chang
Thursday’s movers: Facebook has its best day ever 3:55 p.m. July 25, 2013 - Sue Chang
Boston Scientific, Mead Johnson soar after beating earnings forecasts 9:54 a.m. July 25, 2013 - Russ Britt
Boston Scientific swings to profit; raises outlook 6:56 a.m. July 25, 2013 - MarketWatch.com
Monday’s movers: Apple gains on price-target hike 3:15 p.m. July 22, 2013 - Sue Chang
TMO-LIFE Deal Gains Regulatory Nod - Analyst Blog 4:45 p.m. Nov. 27, 2013 - Zacks.com
Insider Trading Alert - RAI, FL, DTV, MFA And BSX Traded By Insiders 11:30 a.m. Nov. 27, 2013 - TheStreet.com
BSX' Promus PREMIER DES Gets FDA Nod - Analyst Blog 11:10 a.m. Nov. 27, 2013 - Zacks.com
5 Health Services Stocks Dragging The Industry Down 12:04 p.m. Nov. 26, 2013 - TheStreet.com
'Greed Is Good': Hologic Attracts The Value Crowd 9:14 a.m. Nov. 26, 2013 - Seeking Alpha
Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard 5:01 p.m. Nov. 25, 2013 - TheStreet.com
Boston Scientific Receives FDA Approval For Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System 8:02 a.m. Nov. 25, 2013 - benzinga.com
Insider Trading Alert - BSX, VNDA, RLGY, SNDK And VRTX Traded By Insiders 10:30 a.m. Nov. 22, 2013 - TheStreet.com
BSX's Offerings Get FDA and CE Mark - Analyst Blog 5:40 p.m. Nov. 21, 2013 - Zacks.com
Time to Sell the Boston Scientific Turnaround? 11:23 a.m. Nov. 21, 2013 - 247WallSt.com
2013's Big Winners Having A Rough Week 3:28 a.m. Nov. 21, 2013 - Seeking Alpha
BSX Advances with Lotus Valve in Europe - Analyst Blog 1:40 p.m. Nov. 20, 2013 - Zacks.com
Top Oppenheimer Health Care Stocks to Buy for 2014 7:36 a.m. Nov. 20, 2013 - 247WallSt.com
Trade-Ideas: Boston Scientific (BSX) Is Today's Post-Market Leader Stock 8:15 p.m. Nov. 19, 2013 - TheStreet.com
Boston Scientific Receives FDA Clearance, CE Mark Approval for Direxion Torqueable Microcatheter 5:46 p.m. Nov. 19, 2013 - benzinga.com
Medtronic Reports Mixed Quarter In Transitional Year 4:12 p.m. Nov. 19, 2013 - Investors Business Daily
Medtronic Q2 Earnings Beat, But Profit Margins Soft 10:25 a.m. Nov. 19, 2013 - Investors Business Daily
Boston Scientific Vercise Deep Brain Stimulation System Receives CE Mark Approval 4:51 a.m. Nov. 19, 2013 - benzinga.com
HP ProLiant Generation 8 Servers Take Clients to Top 500 and 2 More Heavily Traded Stocks to Follow 3:56 p.m. Nov. 18, 2013 - Wall St. Cheat Sheet
Boston Scientific Says Lotus Meets Co-Primary Endpoints 9:59 a.m. Nov. 15, 2013 - benzinga.com
Press Releases on BSX
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System 9:00 a.m. Nov. 25, 2013 - PR Newswire
Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova 8:00 a.m. Nov. 25, 2013 - PR Newswire
Global Earth Energy, Inc.'s (GLER) Partner Hawk Manufacturing Provides Forecast 1:00 p.m. Nov. 22, 2013 - GlobeNewswire
Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference 9:06 a.m. Nov. 22, 2013 - PR Newswire
Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific 5:01 p.m. Nov. 21, 2013 - PR Newswire
Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion(TM) Torqueable Microcatheter 6:02 p.m. Nov. 19, 2013 - PR Newswire
EBS Technologies Appoints Karl Schweitzer, JD, MBA, Medtronic's Former Vice President and General Manager of Neuromodulation, as a Director 9:50 a.m. Nov. 19, 2013 - BusinessWire
BioLife Solutions Appoints Raymond W. Cohen as Chairman and Joe Schick to Board of Directors 6:00 a.m. Nov. 19, 2013 - PR Newswire
Boston Scientific Vercise(TM) Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia 4:00 a.m. Nov. 19, 2013 - PR Newswire
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe 10:54 a.m. Nov. 15, 2013 - PR Newswire
Financial Results, New Products, and Stock Price Movements - Research Report on Hologic, Johnson & Johnson, Boston Scientific, Elan, and Amedisys 8:00 a.m. Nov. 15, 2013 - PR Newswire
Before the Bell Scans: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc. 9:50 a.m. Nov. 8, 2013 - PR Newswire
FDA Approves Medtronic-Proprietary Software for Use with Non-Medtronic Leads to Detect Defibrillator Lead Issues 9:00 a.m. Nov. 7, 2013 - Thomson Reuters ONE
Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference 3:16 p.m. Nov. 6, 2013 - PR Newswire
MWest Acquires Office Portfolio in North San Jose, California 8:00 a.m. Nov. 6, 2013 - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Shocking News & Research: Boston Scientific, Yingli Green Energy Hold, QUALCOMM, PulteGroup, Regions Financial 8:46 a.m. Nov. 5, 2013 - PR Newswire
Critical Alerts For Microsoft, Procter and Gamble, Amgen, Expedia, and Boston Scientific Released By InvestorsObserver 9:31 a.m. Nov. 4, 2013 - PR Newswire
Boston Scientific Completes Acquisition Of Bard Electrophysiology 10:15 a.m. Nov. 1, 2013 - PR Newswire
Boston Scientific Lotus(TM) Valve System Meets Primary Performance Endpoint In REPRISE II Trial 5:40 p.m. Oct. 31, 2013 - PR Newswire
Valuation
P/E Current
-4.05
P/E Ratio (with extraordinary items)
-93.42
Price to Sales Ratio
1.11
Price to Book Ratio
1.13
Price to Cash Flow Ratio
6.40
Enterprise Value to EBITDA
12.01
Enterprise Value to Sales
2.83
Total Debt to Enterprise Value
0.35
Efficiency
Revenue/Employee
0.30
Income Per Employee
-0.17
Receivables Turnover
5.89
Total Asset Turnover
0.38
Liquidity
Current Ratio
1.71
Quick Ratio
1.21
Cash Ratio
0.12
Profitability
Gross Margin
62.79
Operating Margin
13.71
Pretax Margin
-56.66
Net Margin
-56.12
Return on Assets
-21.16
Return on Equity
-44.65
Return on Total Capital
-30.43
Return on Invested Capital
-30.44
Capital Structure
Total Debt to Total Equity
61.95
Total Debt to Total Capital
38.25
Total Debt to Total Assets
24.81
Long-Term Debt to Equity
61.89
Long-Term Debt to Total Capital
38.22
Boston Scientific Corp. BSX Financials
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 8.05B 8.19B 7.81B 7.62B 7.25B
Cost of Goods Sold (COGS) incl. D&A 3.01B 3.09B 3.06B 2.95B 2.7B
COGS excluding D&A 2.15B 2.25B 2.25B 2.23B 2.01B
Depreciation & Amortization Expense 864M 834M 816M 717M 683M
Depreciation 321M 323M 303M 296M 288M
Amortization of Intangibles 543M 511M 513M 421M 395M
Gross Income 5.04B 5.1B 4.74B 4.67B 4.55B
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 3.6B 3.67B 3.43B 3.38B 3.41B
Research & Development 1.01B 1.04B 939M 895M 886M
Other SG&A 2.59B 2.64B 2.49B 2.48B 2.52B
Other Operating Expense 203M 191M 275M 172M 153M
Unusual Expense 3.38B 2.13B 130M 984M 4.88B
EBIT after Unusual Expense (3.38B) (2.13B) (130M) (984M) (4.88B)
Non Operating Income/Expense 525M (14M) (1.59B) 778M 32M
Non-Operating Interest Income 47M 7M 13M 7M 5M
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 468M 407M 393M 282M 257M
Gross Interest Expense 468M 407M 393M 282M 257M
Interest Capitalized 0 0 0 0 0
Pretax Income (2.03B) (1.31B) (1.06B) 642M (4.11B)
Income Tax 5M (283M) 2M 201M (39M)
Income Tax - Current Domestic 137M (191M) (74M) 53M 33M
Income Tax - Current Foreign 189M (2M) 125M 91M 139M
Income Tax - Deferred Domestic (299M) (130M) (29M) 78M (211M)
Income Tax - Deferred Foreign (22M) 40M (20M) (21M) 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - - 0
Consolidated Net Income (2.04B) (1.03B) (1.07B) 441M (4.07B)
Minority Interest Expense 0 0 0 0 0
Net Income (2.04B) (1.03B) (1.07B) 441M (4.07B)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - - 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.04B) (1.03B) (1.07B) 441M (4.07B)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.04B) (1.03B) (1.07B) 441M (4.07B)
EPS (Basic) (1.36) (0.68) (0.70) 0.29 (2.89)
Basic Shares Outstanding 1.5B 1.51B 1.52B 1.51B 1.41B
EPS (Diluted) (1.36) (0.68) (0.70) 0.29 (2.89)
Diluted Shares Outstanding 1.5B 1.51B 1.52B 1.52B 1.41B
EBITDA 2.1B 2.07B 1.86B 1.84B 1.68B
Boston Scientific Corp. BSX Filings
SEC Filings for Boston Scientific Corp.
Filing Date Document Date Type Category Amended
11/05/2013 09/30/2013 10-Q Quarterly Reports
10/25/2013 10/22/2013 8-K Special Events
10/24/2013 10/22/2013 8-K Special Events
10/24/2013 10/24/2013 8-K Special Events
10/23/2013 10/22/2013 8-K Special Events
08/13/2013 08/08/2013 8-K Special Events
08/09/2013 08/08/2013 8-K Special Events
08/07/2013 06/30/2013 10-Q Quarterly Reports
07/25/2013 07/25/2013 8-K Special Events
07/10/2013 N/A SC 13G Institutional Ownership
07/01/2013 06/28/2013 8-K Special Events
06/28/2013 06/27/2013 8-K Special Events
05/29/2013 N/A S-8 Registration Statement
05/29/2013 05/29/2013 8-K Special Events
05/09/2013 05/07/2013 8-K Special Events
05/07/2013 03/31/2013 10-Q/A Quarterly Reports *
05/07/2013 03/31/2013 10-Q Quarterly Reports
04/25/2013 04/22/2013 8-K Special Events
03/26/2013 05/07/2013 DEF 14A Proxy Statement
03/06/2013 02/28/2013 8-K Special Events
SEC Filings provided by EDGAR Online, Inc.
BSX Boston Scientific Corp. Research Links
Stock Message Board http://investorshangout.com/search?q=BSX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BSX/quote
Stock Chart http://www.otcmarkets.com/stock/BSX/chart
Company Info http://www.otcmarkets.com/stock/BSX/company-info
Recent News http://www.otcmarkets.com/stock/BSX/news
Financials http://www.otcmarkets.com/stock/BSX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BSX/filings
Short Sales http://www.otcmarkets.com/stock/BSX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BSX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BSX/research
Summary http://finance.yahoo.com/q?s=BSX
Historical Prices http://finance.yahoo.com/q/hp?s=BSX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BSX
Basic Chart http://finance.yahoo.com/q/bc?s=BSX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BSX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BSX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BSX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BSX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BSX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BSX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BSX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BSX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BSX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BSX
Balance Sheet http://finance.yahoo.com/q/bs?s=BSX
Cash Flow http://finance.yahoo.com/q/cf?s=BSX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BSX
Market Watch http://www.marketwatch.com/investing/stock/BSX
Bloomberg http://www.bloomberg.com/quote/BSX:US
Morningstar http://quotes.morningstar.com/stock/s?t=BSX
Bussinessweek http://investing.businessweek.com/research/st...ticker=BSX
Barchart http://www.barchart.com/quotes/stocks/BSX
OTC Short Report http://otcshortreport.com/index.php?index=BSX
Investopedia http://www.investopedia.com/markets/stocks/BSX/?wa=0
List of all stock message boards and tickers for NYSE New York Stock Exchange http://investorshangout.com/board?categoryid=NYSE
Boston Scientific Corp. develops, manufactures and markets medical devices that are used in a broad range of interventional medical specialties. The company's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. It operates its business through four geographic reportable segments: United States; EMEA, consisting of Europe, the Middle East and Africa; Japan and Inter-Continental, consisting of Asia Pacific and the Americas operating segments. The reportable segments represent an aggregate of all operating divisions within each segment. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Natick, MA.
BSX Last Price: 11.67
Last Updated: November 28, 2013 7:51 PM EST
BSX Stock Message Board and Forum http://investorshangout.com/search?q=BSX&...mp;yt0=Go!
Boston Scientific Corp. BSX Officers and Executives
Name Age Officer Since Title
Mr. Peter Michael Nicholas 71 1979 Chairman
Mr. Michael F. Mahoney 48 2011 President, Chief Executive Officer & Director
Mr. Kenneth J. Pucel 46 1989 EVP-Global Operations, Quality & Technology
Mr. Jeffrey D. Capello 48 2008 Chief Financial Officer & Executive Vice President
Dr. Keith D. Dawkins 62 2008 Global Chief Medical Officer & Executive VP
Boston Scientific Corp.
One Boston Scientific Place
Natick, Massachusetts 01760-1537
Phone
1 5086508000
Industry
Medical Equipment
Sector
Health Care
Fiscal Year-end
12/2013
View SEC Filings Below
Revenue
$7.25B
Net Income
$-4.07B
Employees
24,000
Annual Report Below for BSX
Boston Scientific Corp. BSX Recent Headlines
MarketWatch News on BSX
Best Buy falls 11% on warning; Tesla fires in focus 4:25 p.m. Nov. 19, 2013 - Sue Chang
Boston Scientific up on device OK; Medtronic stumbles on earnings 11:09 a.m. Nov. 19, 2013 - Russ Britt
A red flag against following billionaires’ trades 10:09 a.m. Nov. 15, 2013 - The Trading Deck
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Apple gains on Icahn letter, Muddy Waters hits NQ 3:26 p.m. Oct. 24, 2013 - Sue Chang
Boston Scientific loss narrows; adjusts guidance 6:49 a.m. Oct. 24, 2013 - MarketWatch.com
Ford, Microsoft, Amazon are stocks to watch 4:00 a.m. Oct. 24, 2013 - Sue Chang
What IBM’s revenue miss really means 9:51 a.m. Oct. 17, 2013 - Mark Hulbert
Bullish technicals vie with debt-ceiling deadline 11:38 a.m. Oct. 15, 2013 - Michael Ashbaugh
Bullish technicals vie with debt-ceiling deadline 11:22 a.m. Oct. 15, 2013 - Michael Ashbaugh
Device firms, Regeneron see gains while general markets fear shutdown 12:36 p.m. Sept. 30, 2013 - Russ Britt
One possible reason why device tax passed in the first place — soaring margins 1:32 p.m. Sept. 26, 2013 - Russ Britt
Investors don't see hope for repeal of Obamacare medical-device tax 10:36 a.m. Sept. 26, 2013 - Russ Britt
Dow industrials reclaim the 50-day average 10:55 a.m. Sept. 12, 2013 - Michael Ashbaugh
Groupon climbs to 14-month high close on upgrade 3:28 p.m. Sept. 5, 2013 - Sue Chang
Tuesday’s movers: Facebook takes a breather 3:41 p.m. Aug. 27, 2013 - Sue Chang
Thursday’s movers: Facebook has its best day ever 3:55 p.m. July 25, 2013 - Sue Chang
Boston Scientific, Mead Johnson soar after beating earnings forecasts 9:54 a.m. July 25, 2013 - Russ Britt
Boston Scientific swings to profit; raises outlook 6:56 a.m. July 25, 2013 - MarketWatch.com
Monday’s movers: Apple gains on price-target hike 3:15 p.m. July 22, 2013 - Sue Chang
TMO-LIFE Deal Gains Regulatory Nod - Analyst Blog 4:45 p.m. Nov. 27, 2013 - Zacks.com
Insider Trading Alert - RAI, FL, DTV, MFA And BSX Traded By Insiders 11:30 a.m. Nov. 27, 2013 - TheStreet.com
BSX' Promus PREMIER DES Gets FDA Nod - Analyst Blog 11:10 a.m. Nov. 27, 2013 - Zacks.com
5 Health Services Stocks Dragging The Industry Down 12:04 p.m. Nov. 26, 2013 - TheStreet.com
'Greed Is Good': Hologic Attracts The Value Crowd 9:14 a.m. Nov. 26, 2013 - Seeking Alpha
Boston Scientific Inc. (BSX): Today's Featured Health Services Laggard 5:01 p.m. Nov. 25, 2013 - TheStreet.com
Boston Scientific Receives FDA Approval For Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System 8:02 a.m. Nov. 25, 2013 - benzinga.com
Insider Trading Alert - BSX, VNDA, RLGY, SNDK And VRTX Traded By Insiders 10:30 a.m. Nov. 22, 2013 - TheStreet.com
BSX's Offerings Get FDA and CE Mark - Analyst Blog 5:40 p.m. Nov. 21, 2013 - Zacks.com
Time to Sell the Boston Scientific Turnaround? 11:23 a.m. Nov. 21, 2013 - 247WallSt.com
2013's Big Winners Having A Rough Week 3:28 a.m. Nov. 21, 2013 - Seeking Alpha
BSX Advances with Lotus Valve in Europe - Analyst Blog 1:40 p.m. Nov. 20, 2013 - Zacks.com
Top Oppenheimer Health Care Stocks to Buy for 2014 7:36 a.m. Nov. 20, 2013 - 247WallSt.com
Trade-Ideas: Boston Scientific (BSX) Is Today's Post-Market Leader Stock 8:15 p.m. Nov. 19, 2013 - TheStreet.com
Boston Scientific Receives FDA Clearance, CE Mark Approval for Direxion Torqueable Microcatheter 5:46 p.m. Nov. 19, 2013 - benzinga.com
Medtronic Reports Mixed Quarter In Transitional Year 4:12 p.m. Nov. 19, 2013 - Investors Business Daily
Medtronic Q2 Earnings Beat, But Profit Margins Soft 10:25 a.m. Nov. 19, 2013 - Investors Business Daily
Boston Scientific Vercise Deep Brain Stimulation System Receives CE Mark Approval 4:51 a.m. Nov. 19, 2013 - benzinga.com
HP ProLiant Generation 8 Servers Take Clients to Top 500 and 2 More Heavily Traded Stocks to Follow 3:56 p.m. Nov. 18, 2013 - Wall St. Cheat Sheet
Boston Scientific Says Lotus Meets Co-Primary Endpoints 9:59 a.m. Nov. 15, 2013 - benzinga.com
Press Releases on BSX
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System 9:00 a.m. Nov. 25, 2013 - PR Newswire
Upcoming Webinars, FDA Clearances, Preclinical Data Presentations, Completed Acquisitions and Financial Results - Research Report on Teva, Boston Scientific, Alnylam, Wright Medical, and Onconova 8:00 a.m. Nov. 25, 2013 - PR Newswire
Global Earth Energy, Inc.'s (GLER) Partner Hawk Manufacturing Provides Forecast 1:00 p.m. Nov. 22, 2013 - GlobeNewswire
Boston Scientific To Participate In 25th Annual Piper Jaffray Healthcare Conference 9:06 a.m. Nov. 22, 2013 - PR Newswire
Susan Lisa Named Vice President Of Investor Relations Of Boston Scientific 5:01 p.m. Nov. 21, 2013 - PR Newswire
Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion(TM) Torqueable Microcatheter 6:02 p.m. Nov. 19, 2013 - PR Newswire
EBS Technologies Appoints Karl Schweitzer, JD, MBA, Medtronic's Former Vice President and General Manager of Neuromodulation, as a Director 9:50 a.m. Nov. 19, 2013 - BusinessWire
BioLife Solutions Appoints Raymond W. Cohen as Chairman and Joe Schick to Board of Directors 6:00 a.m. Nov. 19, 2013 - PR Newswire
Boston Scientific Vercise(TM) Deep Brain Stimulation System Receives CE Mark Approval for Treatment of Dystonia 4:00 a.m. Nov. 19, 2013 - PR Newswire
Boston Scientific Announces First Commercial Implants Of The Lotus(TM) Valve System in Europe 10:54 a.m. Nov. 15, 2013 - PR Newswire
Financial Results, New Products, and Stock Price Movements - Research Report on Hologic, Johnson & Johnson, Boston Scientific, Elan, and Amedisys 8:00 a.m. Nov. 15, 2013 - PR Newswire
Before the Bell Scans: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc. 9:50 a.m. Nov. 8, 2013 - PR Newswire
FDA Approves Medtronic-Proprietary Software for Use with Non-Medtronic Leads to Detect Defibrillator Lead Issues 9:00 a.m. Nov. 7, 2013 - Thomson Reuters ONE
Boston Scientific To Participate In 2013 Credit Suisse Healthcare Conference 3:16 p.m. Nov. 6, 2013 - PR Newswire
MWest Acquires Office Portfolio in North San Jose, California 8:00 a.m. Nov. 6, 2013 - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Shocking News & Research: Boston Scientific, Yingli Green Energy Hold, QUALCOMM, PulteGroup, Regions Financial 8:46 a.m. Nov. 5, 2013 - PR Newswire
Critical Alerts For Microsoft, Procter and Gamble, Amgen, Expedia, and Boston Scientific Released By InvestorsObserver 9:31 a.m. Nov. 4, 2013 - PR Newswire
Boston Scientific Completes Acquisition Of Bard Electrophysiology 10:15 a.m. Nov. 1, 2013 - PR Newswire
Boston Scientific Lotus(TM) Valve System Meets Primary Performance Endpoint In REPRISE II Trial 5:40 p.m. Oct. 31, 2013 - PR Newswire
Valuation
P/E Current
-4.05
P/E Ratio (with extraordinary items)
-93.42
Price to Sales Ratio
1.11
Price to Book Ratio
1.13
Price to Cash Flow Ratio
6.40
Enterprise Value to EBITDA
12.01
Enterprise Value to Sales
2.83
Total Debt to Enterprise Value
0.35
Efficiency
Revenue/Employee
0.30
Income Per Employee
-0.17
Receivables Turnover
5.89
Total Asset Turnover
0.38
Liquidity
Current Ratio
1.71
Quick Ratio
1.21
Cash Ratio
0.12
Profitability
Gross Margin
62.79
Operating Margin
13.71
Pretax Margin
-56.66
Net Margin
-56.12
Return on Assets
-21.16
Return on Equity
-44.65
Return on Total Capital
-30.43
Return on Invested Capital
-30.44
Capital Structure
Total Debt to Total Equity
61.95
Total Debt to Total Capital
38.25
Total Debt to Total Assets
24.81
Long-Term Debt to Equity
61.89
Long-Term Debt to Total Capital
38.22
Boston Scientific Corp. BSX Financials
Fiscal year is January-December. All values USD millions. 2008 2009 2010 2011 2012 5-year trend
Sales/Revenue 8.05B 8.19B 7.81B 7.62B 7.25B
Cost of Goods Sold (COGS) incl. D&A 3.01B 3.09B 3.06B 2.95B 2.7B
COGS excluding D&A 2.15B 2.25B 2.25B 2.23B 2.01B
Depreciation & Amortization Expense 864M 834M 816M 717M 683M
Depreciation 321M 323M 303M 296M 288M
Amortization of Intangibles 543M 511M 513M 421M 395M
Gross Income 5.04B 5.1B 4.74B 4.67B 4.55B
2008 2009 2010 2011 2012 5-year trend
SG&A Expense 3.6B 3.67B 3.43B 3.38B 3.41B
Research & Development 1.01B 1.04B 939M 895M 886M
Other SG&A 2.59B 2.64B 2.49B 2.48B 2.52B
Other Operating Expense 203M 191M 275M 172M 153M
Unusual Expense 3.38B 2.13B 130M 984M 4.88B
EBIT after Unusual Expense (3.38B) (2.13B) (130M) (984M) (4.88B)
Non Operating Income/Expense 525M (14M) (1.59B) 778M 32M
Non-Operating Interest Income 47M 7M 13M 7M 5M
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 468M 407M 393M 282M 257M
Gross Interest Expense 468M 407M 393M 282M 257M
Interest Capitalized 0 0 0 0 0
Pretax Income (2.03B) (1.31B) (1.06B) 642M (4.11B)
Income Tax 5M (283M) 2M 201M (39M)
Income Tax - Current Domestic 137M (191M) (74M) 53M 33M
Income Tax - Current Foreign 189M (2M) 125M 91M 139M
Income Tax - Deferred Domestic (299M) (130M) (29M) 78M (211M)
Income Tax - Deferred Foreign (22M) 40M (20M) (21M) 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 - - 0
Consolidated Net Income (2.04B) (1.03B) (1.07B) 441M (4.07B)
Minority Interest Expense 0 0 0 0 0
Net Income (2.04B) (1.03B) (1.07B) 441M (4.07B)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - - 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.04B) (1.03B) (1.07B) 441M (4.07B)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (2.04B) (1.03B) (1.07B) 441M (4.07B)
EPS (Basic) (1.36) (0.68) (0.70) 0.29 (2.89)
Basic Shares Outstanding 1.5B 1.51B 1.52B 1.51B 1.41B
EPS (Diluted) (1.36) (0.68) (0.70) 0.29 (2.89)
Diluted Shares Outstanding 1.5B 1.51B 1.52B 1.52B 1.41B
EBITDA 2.1B 2.07B 1.86B 1.84B 1.68B
Boston Scientific Corp. BSX Filings
SEC Filings for Boston Scientific Corp.
Filing Date Document Date Type Category Amended
11/05/2013 09/30/2013 10-Q Quarterly Reports
10/25/2013 10/22/2013 8-K Special Events
10/24/2013 10/22/2013 8-K Special Events
10/24/2013 10/24/2013 8-K Special Events
10/23/2013 10/22/2013 8-K Special Events
08/13/2013 08/08/2013 8-K Special Events
08/09/2013 08/08/2013 8-K Special Events
08/07/2013 06/30/2013 10-Q Quarterly Reports
07/25/2013 07/25/2013 8-K Special Events
07/10/2013 N/A SC 13G Institutional Ownership
07/01/2013 06/28/2013 8-K Special Events
06/28/2013 06/27/2013 8-K Special Events
05/29/2013 N/A S-8 Registration Statement
05/29/2013 05/29/2013 8-K Special Events
05/09/2013 05/07/2013 8-K Special Events
05/07/2013 03/31/2013 10-Q/A Quarterly Reports *
05/07/2013 03/31/2013 10-Q Quarterly Reports
04/25/2013 04/22/2013 8-K Special Events
03/26/2013 05/07/2013 DEF 14A Proxy Statement
03/06/2013 02/28/2013 8-K Special Events
SEC Filings provided by EDGAR Online, Inc.
BSX Boston Scientific Corp. Research Links
Stock Message Board http://investorshangout.com/search?q=BSX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BSX/quote
Stock Chart http://www.otcmarkets.com/stock/BSX/chart
Company Info http://www.otcmarkets.com/stock/BSX/company-info
Recent News http://www.otcmarkets.com/stock/BSX/news
Financials http://www.otcmarkets.com/stock/BSX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BSX/filings
Short Sales http://www.otcmarkets.com/stock/BSX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BSX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BSX/research
Summary http://finance.yahoo.com/q?s=BSX
Historical Prices http://finance.yahoo.com/q/hp?s=BSX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BSX
Basic Chart http://finance.yahoo.com/q/bc?s=BSX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BSX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BSX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BSX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BSX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BSX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BSX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BSX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BSX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BSX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BSX
Balance Sheet http://finance.yahoo.com/q/bs?s=BSX
Cash Flow http://finance.yahoo.com/q/cf?s=BSX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BSX
Market Watch http://www.marketwatch.com/investing/stock/BSX
Bloomberg http://www.bloomberg.com/quote/BSX:US
Morningstar http://quotes.morningstar.com/stock/s?t=BSX
Bussinessweek http://investing.businessweek.com/research/st...ticker=BSX
Barchart http://www.barchart.com/quotes/stocks/BSX
OTC Short Report http://otcshortreport.com/index.php?index=BSX
Investopedia http://www.investopedia.com/markets/stocks/BSX/?wa=0
List of all stock message boards and tickers for NYSE New York Stock Exchange http://investorshangout.com/board?categoryid=NYSE
